{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T22:01:22Z","timestamp":1780696882188,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,7]],"date-time":"2018-03-07T00:00:00Z","timestamp":1520380800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["16H02636"],"award-info":[{"award-number":["16H02636"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.jphs.2018.01.008","type":"journal-article","created":{"date-parts":[[2018,3,14]],"date-time":"2018-03-14T04:42:27Z","timestamp":1521002547000},"page":"228-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Optimizing the dosing schedule of l-asparaginase improves its anti-tumor activity in breast tumor-bearing mice"],"prefix":"10.1016","volume":"136","author":[{"given":"Shoya","family":"Shiromizu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kusunose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Ohdo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2018.01.008_bib1","doi-asserted-by":"crossref","first-page":"3678","DOI":"10.1172\/JCI69600","article-title":"Glutamine and cancer: cell biology, physiology, and clinical opportunities","volume":"123","author":"Hensley","year":"2013","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jphs.2018.01.008_bib2","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S1525-1578(10)60513-2","article-title":"Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expression","volume":"6","author":"Irino","year":"2004","journal-title":"J\u00a0Mol Diagn"},{"key":"10.1016\/j.jphs.2018.01.008_bib3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1365-2141.2005.05945.x","article-title":"Expression levels of asparagine synthetase in blasts from children and adults with acute lymphoblastic leukaemia","volume":"132","author":"Leslie","year":"2006","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jphs.2018.01.008_bib4","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.critrevonc.2006.07.009","article-title":"Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia","volume":"61","author":"Narta","year":"2007","journal-title":"Crit Rev Oncol"},{"key":"10.1016\/j.jphs.2018.01.008_bib5","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/leu.2008.165","article-title":"Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study","volume":"22","author":"Appel","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.jphs.2018.01.008_bib6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/1097-0142(197002)25:2<306::AID-CNCR2820250206>3.0.CO;2-H","article-title":"E.\u00a0coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children","volume":"25","author":"Tallal","year":"1970","journal-title":"Cancer"},{"key":"10.1016\/j.jphs.2018.01.008_bib7","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.1158\/1535-7163.MCT-08-0589","article-title":"Asparagine synthetase is a predictive biomarker of L-asparaginase activity in ovarian cancer cell lines","volume":"7","author":"Lorenzi","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.jphs.2018.01.008_bib8","doi-asserted-by":"crossref","first-page":"e13892","DOI":"10.1371\/journal.pone.0013892","article-title":"Cell-cycle inhibition by Helicobacter pylori L-asparaginase","volume":"5","author":"Scotti","year":"2010","journal-title":"PloS one"},{"key":"10.1016\/j.jphs.2018.01.008_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/bjc.2013.293","article-title":"Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma","volume":"109","author":"Zhang","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jphs.2018.01.008_bib10","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1517\/17425247.2.4.667","article-title":"Chronopharmacology and controlled drug release","volume":"2","author":"Lemmer","year":"2005","journal-title":"Expet Opin Drug Deliv"},{"key":"10.1016\/j.jphs.2018.01.008_bib11","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2133\/dmpk.22.3","article-title":"Chronopharmacology focused on biological clock","volume":"22","author":"Ohdo","year":"2007","journal-title":"Drug Metabol Pharmacokinet"},{"key":"10.1016\/j.jphs.2018.01.008_bib12","first-page":"7277","article-title":"A\u00a0molecular mechanism regulating circadian expression of vascular endothelial growth factor in tumor cells","volume":"63","author":"Koyanagi","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.jphs.2018.01.008_bib13","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1038\/sj.leu.2404423","article-title":"The downregulation of asparagine synthetase expression can increase the sensitivity of cells resistant to l-asparaginase","volume":"20","author":"Li","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.jphs.2018.01.008_bib14","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jphs.2018.01.008_bib15","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nature07823","article-title":"c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism","volume":"458","author":"Gao","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.jphs.2018.01.008_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.semcancer.2005.04.005","article-title":"Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?","volume":"15","author":"Fuchs","year":"2005","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jphs.2018.01.008_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00726-015-2061-7","article-title":"Omega-Amidase: an underappreciated, but important enzyme in L-glutamine and L-asparagine metabolism; relevance to sulfur and nitrogen metabolism, tumor biology and hyperammonemic diseases","volume":"48","author":"Cooper","year":"2016","journal-title":"Amino Acids"},{"key":"10.1016\/j.jphs.2018.01.008_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11457","article-title":"Asparagine promotes cancer cell proliferation through use as an amino acid exchange factor","volume":"7","author":"Krall","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.jphs.2018.01.008_bib19","first-page":"1303","article-title":"Declined asparagine synthetase mRNA expression and enhanced sensitivity to asparaginase in HL-60 cells committed to monocytic differentiation","volume":"29","author":"Hashimoto","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.jphs.2018.01.008_bib20","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/ijc.2910220615","article-title":"Mechanism of sensitivity of cultured pancreatic carcinoma to asparaginase","volume":"22","author":"Wu","year":"1978","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jphs.2018.01.008_bib21","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/85507","article-title":"Changing the dosing schedule minimizes the disruptive effects of interferon on clock function","volume":"7","author":"Ohdo","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jphs.2018.01.008_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jphs.2017.02.008","article-title":"Effect of a dosing-time on quetiapine-induced acute hyperglycemia in mice","volume":"133","author":"Kapse","year":"2017","journal-title":"J\u00a0Pharmacol Sci"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861318300458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861318300458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:58:26Z","timestamp":1761163106000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861318300458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S1347861318300458"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2018.01.008","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimizing the dosing schedule of l-asparaginase improves its anti-tumor activity in breast tumor-bearing mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2018.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}